PEG: Will It Come Back to You? Polyethelyne Glycol Immunogenicity, COVID Vaccines, and the Case for New PEG Derivatives and Alternatives
Yi Wen Kong, Erik C. Dreaden
Abstract
OPINION article Front. Bioeng. Biotechnol., 27 April 2022Sec. Nanobiotechnology https://doi.org/10.3389/fbioe.2022.879988
Topics & Concepts
ImmunogenicityPEG ratioCoronavirus disease 2019 (COVID-19)VirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPEGylationMedicineBusinessImmunologyAntibodyInternal medicineInfectious disease (medical specialty)FinanceDiseaseOutbreakSARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchInhalation and Respiratory Drug Delivery